World's Best Scientists 2026 revealed!
Hervé Avet-Loiseau

Hervé Avet-Loiseau

Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
122
Citations
62970
World Ranking
3440
National Ranking
95

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Hervé Avet-Loiseau is a researcher affiliated with Inserm in France, with a primary focus on medical and molecular biological sciences. Their research has concentrated significantly on hematology and oncology, particularly in the study and treatment of multiple myeloma. The scientist's work spans both clinical and molecular dimensions, incorporating genetics and cancer research into their investigations.

The main fields of study for Hervé Avet-Loiseau are Medicine and Biochemistry, Genetics and Molecular Biology. Within these broader areas, the subfields of focus include:

  • Hematology
  • Molecular Biology
  • Oncology
  • Genetics
  • Cancer Research

The primary topics covered in their research encompass multiple myeloma research and treatments, protein degradation and inhibitors, peptidase inhibition and analysis, cancer treatment and pharmacology, glycosylation and glycoproteins research, cancer genomics and diagnostics, and CAR-T cell therapy research. These topics illustrate a comprehensive examination of the biological mechanisms underlying cancer and the development of therapeutic strategies.

Hervé Avet-Loiseau has contributed to numerous publications. Some recent notable papers include:

  • Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma, 2022, New England Journal of Medicine
  • A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma, 2020, Blood Advances
  • Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma, 2021, Nature Communications
  • Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set, 2020, Blood
  • Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial, 2021, The Lancet Oncology

The venues where Hervé Avet-Loiseau frequently publishes their research reflect a focus on hematology and oncology and include:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology
  • Leukemia
  • Haematologica

Collaboration is a significant aspect of Hervé Avet-Loiseau's research activities. Frequent co-authors include:

  • Jill Corre
  • Philippe Moreau
  • Aurore Perrot
  • Xavier Leleu
  • Cyrille Touzeau

This body of work underlines a sustained involvement in advancing understanding and treatment options for multiple myeloma, often through collaborative projects with other specialists in the field and contributions to well-regarded scientific journals.

Best Publications

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

    Michel Attal;Valerie Lauwers-Cances;Gerald Marit;Denis Caillot

  • Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial.

    Thierry Facon;Jean Yves Mary;Cyrille Hulin;Lotfi Benboubker

  • Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

    Michel Attal;Valerie Lauwers-Cances;Cyrille Hulin;Xavier Leleu

  • Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome

    Hervé Avet-Loiseau;Michel Attal;Philippe Moreau;Catherine Charbonnel

  • International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.

    R Fonseca;P L Bergsagel;J Drach;J Shaughnessy

  • Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    S. Vincent Rajkumar;Jean Luc Harousseau;Brian Durie;Kenneth C. Anderson

  • Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

    R A Kyle;B G M Durie;S V Rajkumar;O Landgren

  • Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

    Niccolo Bolli;Hervé Avet-Loiseau;David C. Wedge;Peter Van Loo

  • Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

    Philippe Moreau;Michel Attal;Cyrille Hulin;Bertrand Arnulf

  • Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    Pieter Sonneveld;Hervé Avet-Loiseau;Sagar Lonial;Saad Usmani

  • Genetics and Cytogenetics of Multiple Myeloma A Workshop Report

    Rafael Fonseca;Bart Barlogie;Regis Bataille;Christian Bastard

  • Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

    Lotfi Benboubker;Meletios Athanasios Dimopoulos;Angela Dispenzieri;John Catalano

  • Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

    Michel Attal;Jean-Luc Harousseau;Serge Leyvraz;Chantal Doyen

  • Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    P. Moreau;J. San Miguel;P. Sonneveld;M. V. Mateos

  • Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.

    Jean-Luc Harousseau;Michel Attal;Hervé Avet-Loiseau;Gerald Marit

  • IMWG consensus on risk stratification in multiple myeloma

    W J Chng;A Dispenzieri;C-S Chim;R Fonseca

  • Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Commentary

    Giampaolo Merlini;Michel Attal;Jean-Luc Harousseau;Serge Leyvraz

Frequent Co-Authors

Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Michel Attal
Michel Attal Janssen (Belgium)
Philippe Moreau
Philippe Moreau University of Nantes
Thierry Facon
Thierry Facon Centre Hospitalier Régional et Universitaire de Lille
Jean-Luc Harousseau
Jean-Luc Harousseau University of Nantes
Denis Caillot
Denis Caillot Grenoble Alpes University
Xavier Leleu
Xavier Leleu Harvard University
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Régis Bataille
Régis Bataille University of Angers
Paul G. Richardson
Paul G. Richardson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean becoming a doctor—there are many allied health professions and nursing pathways to consider. For those seeking flexibility, online nursing degrees offer practical options that can be tailored to your schedule and budget.

If you already have an RN license, you might consider the cheapest rn to bsn programs to earn your BSN affordably and conveniently online. Interested in advanced research or teaching roles? Accredited phd nursing programs can be found with online learning formats, providing greater access to doctorate-level education.

For those from non-nursing fields, some colleges now feature direct entry msn programs for non-nursing majors online, helping career changers earn their master’s in nursing in less time. Additionally, if you’re starting out and have concerns about acceptance rates, consider reviewing the easiest nursing programs to get into.

Whether you’re looking for speed, affordability, or accessibility, these online pathways make a healthcare career more achievable for many students.

Best Scientists Citing Hervé Avet-Loiseau

Trending Scientists